Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma

QR Code

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma

Background: Malignant mesothelioma is an aggressive, almost uniformly fatal tumor, primarily caused by exposure to asbestos. Since the recent discovery that serum mesothelin is a sensitive and highly specific biomarker for mesothelioma, one of the key issues raised is whether mesothelin levels repre...

Full description

Bibliographic Details
Main Authors:	Creaney, J., Olsen, N., Brims, Fraser, Dick, I., Musk, A., De Klerk, N., Skates, S., Robinson, B.
Format:	Journal Article
Published:	American Association for Cancer Research Inc 2010
Online Access:	http://hdl.handle.net/20.500.11937/9994

Similar Items

Asbestos Related non-Malignant Pleural Disease and Mesothelioma
by: Musk, B., et al.
Published: (2016)

Asbestos exposure and histological subtype of malignant mesothelioma
by: Franklin, P., et al.
Published: (2016)

Validation of an Asbestos Job-Exposure Matrix: Exposure-Response Relationships for Malignant Mesothelioma
by: Kamiya, H., et al.
Published: (2018)

Risk factors for malignant mesothelioma in people with no known exposure to asbestos
by: Musk, B., et al.
Published: (2017)

Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
by: Olsen, N., et al.
Published: (2011)

Pattern of malignant mesothelioma incidence and occupational exposure to asbestos in Western Australia.
by: Musk, A., et al.
Published: (2015)

Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)

Incidence of malignant mesothelioma in Aboriginal people in Western Australia.
by: Franklin, P., et al.
Published: (2016)

Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
by: Sneddon, S., et al.
Published: (2015)

Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
by: Reid, Alison, et al.
Published: (2009)

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
by: Robinson, C., et al.
Published: (2014)

Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)

Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)

Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma
by: Muruganandan, S., et al.
Published: (2017)

Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom
by: Reid, Alison, et al.
Published: (2018)

Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients
by: Finn, R., et al.
Published: (2012)

Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans
by: Robinson, C., et al.
Published: (2014)

A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis
by: Brims, Fraser, et al.
Published: (2016)

Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
by: De Klerk, N., et al.
Published: (2013)

ROUTINELY COLLECTED CLINICAL AND LABORATORY DATA CAN RELIABLY PREDICT LONGER SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2014)

Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma
by: Brims, Fraser, et al.
Published: (2014)

Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia
by: Alfonso, Helman, et al.
Published: (2010)

Autoimmune antibodies and asbestos exposure: Evidence from Wittenoom, Western Australia
by: Reid, Alison, et al.
Published: (2018)

SURVIVAL IN MESOTHELIOMA: AN ANALYSIS OF DIFFERENT DIAGNOSTIC TECHNIQUES
by: Muruganandan, S., et al.
Published: (2016)

Lowdose CT screen-detected malignant and non-malignant findings in a Western Australian Asbestos-exposed cohort: results from the first 5 years of screening
by: Harris, E., et al.
Published: (2018)

A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)

Asbestos Related Pleural Diseases
by: Brims, Fraser, et al.
Published: (2016)

Mesothelioma risk After 40 Years Since First Exposure to Asbestos: a Pooled Analysis
by: Reid, Alison, et al.
Published: (2014)

Diagnosis of asbestos-related lung diseases
by: Harris, E., et al.
Published: (2019)

PLEURAL PLAQUES DO NOT INCREASE LUNG CANCER RISK IN ASBESTOS-EXPOSED
by: Kong, K., et al.
Published: (2018)

The continual search for ideal biomarkers for mesothelioma: The hurdles
by: Brims, Fraser, et al.
Published: (2013)

VALIDATION OF AN ASBESTOS JOB EXPOSURE MATRIX USING LUNG FIBRE COUNTS
by: Franklin, P., et al.
Published: (2015)

12 MONTHS OF LOW DOSE CT SCAN SCREENING AN ASBESTOS EXPOSED POPULATION: RESULTS FROM THE WESTERN AUSTRALIA ASBESTOS REVIEW PROGRAM
by: Brims, Fraser, et al.
Published: (2014)

12 Months Of Low Dose CT Scan Screening An Asbestos Exposed Population: Results From The Western Australia Asbestos Review Program
by: Brims, Fraser, et al.
Published: (2014)

Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up
by: Berry, G., et al.
Published: (2012)

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
by: Harris, E., et al.
Published: (2018)

Ultra low dose CT screen-detected non-malignant incidental findings in the Western Australian Asbestos Review Programme
by: Murray, C., et al.
Published: (2016)

LUNG CANCER SCREENING IN THE WESTERN AUSTRALIAN ASBESTOS REVIEW PROGRAM
by: Harris, E., et al.
Published: (2018)

Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0614vqq6slmupqipd2k24ibraa